Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Stress | 6 | 2022 | 131 | 1.880 |
Why?
|
Heart Diseases | 5 | 2022 | 2790 | 0.550 |
Why?
|
Heart Transplantation | 3 | 2022 | 3123 | 0.530 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2014 | 272 | 0.460 |
Why?
|
Ventricular Function, Right | 3 | 2014 | 592 | 0.440 |
Why?
|
Survivors | 5 | 2020 | 2291 | 0.410 |
Why?
|
Pyrroles | 5 | 2009 | 1143 | 0.400 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2018 | 686 | 0.390 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2020 | 1265 | 0.390 |
Why?
|
Anthracyclines | 4 | 2016 | 288 | 0.380 |
Why?
|
Transplantation | 1 | 2012 | 217 | 0.360 |
Why?
|
Indoles | 5 | 2009 | 1838 | 0.350 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6489 | 0.340 |
Why?
|
Hodgkin Disease | 2 | 2014 | 1415 | 0.320 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2702 | 0.320 |
Why?
|
Exercise Test | 2 | 2015 | 2075 | 0.320 |
Why?
|
Heart | 8 | 2015 | 4465 | 0.310 |
Why?
|
Echocardiography, Doppler | 1 | 2011 | 934 | 0.290 |
Why?
|
Antineoplastic Agents | 8 | 2012 | 13668 | 0.260 |
Why?
|
Radiation Injuries | 5 | 2015 | 1178 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 3 | 2009 | 5529 | 0.240 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1912 | 0.230 |
Why?
|
Cardiovascular Diseases | 6 | 2020 | 15161 | 0.210 |
Why?
|
Heart Defects, Congenital | 3 | 2015 | 4586 | 0.210 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2016 | 692 | 0.200 |
Why?
|
Stroke Volume | 4 | 2011 | 5008 | 0.200 |
Why?
|
Antibodies, Monoclonal | 2 | 2009 | 9275 | 0.200 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 455 | 0.190 |
Why?
|
Cardiac Surgical Procedures | 2 | 2014 | 3533 | 0.190 |
Why?
|
Blood Pressure | 3 | 2014 | 8551 | 0.190 |
Why?
|
Radiotherapy | 4 | 2015 | 1525 | 0.180 |
Why?
|
Heart Ventricles | 3 | 2020 | 3820 | 0.180 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17449 | 0.170 |
Why?
|
Propanolamines | 2 | 2016 | 167 | 0.170 |
Why?
|
Heart Atria | 1 | 2005 | 1356 | 0.170 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1132 | 0.160 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2018 | 57 | 0.160 |
Why?
|
Neoplasms | 7 | 2015 | 21672 | 0.150 |
Why?
|
Gastrointestinal Stromal Tumors | 3 | 2009 | 643 | 0.150 |
Why?
|
Mitral Valve Insufficiency | 2 | 2005 | 1421 | 0.150 |
Why?
|
Child | 12 | 2022 | 77679 | 0.140 |
Why?
|
Echocardiography | 10 | 2018 | 5103 | 0.140 |
Why?
|
Mitral Valve | 1 | 2005 | 1490 | 0.140 |
Why?
|
Coronary Angiography | 2 | 2022 | 4578 | 0.140 |
Why?
|
Respiration | 4 | 2000 | 1651 | 0.130 |
Why?
|
Carbazoles | 1 | 2016 | 226 | 0.130 |
Why?
|
Myocytes, Cardiac | 2 | 2022 | 1637 | 0.130 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2016 | 859 | 0.120 |
Why?
|
Heart Failure | 4 | 2016 | 10905 | 0.120 |
Why?
|
Follow-Up Studies | 8 | 2014 | 39045 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2008 | 2455 | 0.120 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2016 | 1240 | 0.120 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2012 | 364 | 0.120 |
Why?
|
Young Adult | 9 | 2018 | 56436 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5442 | 0.110 |
Why?
|
Microtubule-Associated Proteins | 1 | 2018 | 1086 | 0.110 |
Why?
|
DNA Damage | 1 | 2022 | 2432 | 0.110 |
Why?
|
Ventricular Function, Left | 5 | 2016 | 3669 | 0.100 |
Why?
|
Adult | 21 | 2020 | 214035 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2020 | 1541 | 0.100 |
Why?
|
Transposition of Great Vessels | 1 | 2015 | 589 | 0.100 |
Why?
|
Alternative Splicing | 1 | 2016 | 1118 | 0.100 |
Why?
|
Ventricular Remodeling | 2 | 2016 | 1224 | 0.100 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2015 | 1624 | 0.100 |
Why?
|
Humans | 42 | 2022 | 744220 | 0.100 |
Why?
|
Child, Preschool | 7 | 2018 | 40992 | 0.090 |
Why?
|
Ventricular Function | 1 | 2012 | 416 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1378 | 0.090 |
Why?
|
Myocardial Ischemia | 3 | 2019 | 2148 | 0.090 |
Why?
|
Male | 27 | 2020 | 350027 | 0.090 |
Why?
|
Pulmonary Valve | 1 | 2014 | 437 | 0.090 |
Why?
|
Oxygen Consumption | 2 | 2015 | 1869 | 0.090 |
Why?
|
Neurogenesis | 1 | 2016 | 838 | 0.090 |
Why?
|
Female | 27 | 2020 | 380197 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2016 | 850 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2014 | 770 | 0.080 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 709 | 0.080 |
Why?
|
Infant, Newborn | 2 | 2020 | 25618 | 0.080 |
Why?
|
Breast | 1 | 1997 | 1969 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2016 | 2072 | 0.080 |
Why?
|
Adolescent | 8 | 2018 | 85759 | 0.080 |
Why?
|
Benzenesulfonates | 1 | 2009 | 169 | 0.080 |
Why?
|
Syncope | 2 | 2002 | 429 | 0.080 |
Why?
|
Societies, Medical | 1 | 2019 | 3741 | 0.080 |
Why?
|
Mediastinal Neoplasms | 1 | 2010 | 421 | 0.070 |
Why?
|
Prognosis | 3 | 2022 | 29050 | 0.070 |
Why?
|
Niacinamide | 1 | 2009 | 416 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6938 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2020 | 77426 | 0.070 |
Why?
|
Respiratory Physiological Phenomena | 1 | 1987 | 188 | 0.070 |
Why?
|
Dobutamine | 2 | 1996 | 123 | 0.070 |
Why?
|
Phenylurea Compounds | 1 | 2009 | 527 | 0.070 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4776 | 0.070 |
Why?
|
Ventricular Pressure | 2 | 2014 | 199 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 731 | 0.070 |
Why?
|
Risk Factors | 9 | 2016 | 72280 | 0.070 |
Why?
|
Middle Aged | 15 | 2018 | 213367 | 0.070 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2009 | 608 | 0.070 |
Why?
|
Cardiotonic Agents | 2 | 2000 | 535 | 0.060 |
Why?
|
Posture | 2 | 2000 | 958 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2012 | 832 | 0.060 |
Why?
|
Risk Assessment | 4 | 2016 | 23337 | 0.060 |
Why?
|
Feasibility Studies | 3 | 2012 | 5076 | 0.060 |
Why?
|
Cardiology | 1 | 2015 | 1668 | 0.060 |
Why?
|
Hemodynamics | 1 | 2014 | 4199 | 0.060 |
Why?
|
Medical Oncology | 1 | 2015 | 2265 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 1534 | 0.060 |
Why?
|
Genotype | 1 | 2018 | 12956 | 0.060 |
Why?
|
Reproducibility of Results | 5 | 2012 | 19907 | 0.060 |
Why?
|
Prospective Studies | 5 | 2015 | 53280 | 0.060 |
Why?
|
Autonomic Nervous System | 2 | 1991 | 671 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1913 | 0.050 |
Why?
|
Boston | 2 | 2015 | 9311 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2009 | 10949 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2007 | 1677 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3778 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2008 | 876 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4044 | 0.050 |
Why?
|
Heart Rate | 3 | 2015 | 4092 | 0.050 |
Why?
|
Hypothyroidism | 1 | 2006 | 659 | 0.050 |
Why?
|
Hypertension | 3 | 2014 | 8480 | 0.050 |
Why?
|
Cell Survival | 2 | 2009 | 5881 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15538 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2005 | 1423 | 0.050 |
Why?
|
Lung | 2 | 2015 | 9852 | 0.050 |
Why?
|
Disease Management | 1 | 2012 | 2458 | 0.050 |
Why?
|
Cerebrovascular Disorders | 1 | 2008 | 1504 | 0.050 |
Why?
|
Hong Kong | 1 | 2020 | 148 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15070 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1660 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3508 | 0.050 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12244 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5709 | 0.040 |
Why?
|
Aged | 10 | 2018 | 163253 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1987 | 1537 | 0.040 |
Why?
|
Piperazines | 1 | 2009 | 2491 | 0.040 |
Why?
|
Atropine | 2 | 1996 | 244 | 0.040 |
Why?
|
Signal Transduction | 3 | 2012 | 23404 | 0.040 |
Why?
|
Myocardium | 3 | 2009 | 4776 | 0.040 |
Why?
|
Survival Analysis | 2 | 2009 | 10250 | 0.040 |
Why?
|
Infant | 2 | 2018 | 35129 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2636 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14726 | 0.040 |
Why?
|
Rats | 6 | 2009 | 24273 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 2218 | 0.040 |
Why?
|
Pyrimidines | 1 | 2009 | 2940 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2822 | 0.040 |
Why?
|
Neurons | 1 | 2016 | 9335 | 0.040 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2016 | 26 | 0.040 |
Why?
|
Survival Rate | 1 | 2011 | 12781 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2016 | 70 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2009 | 10480 | 0.030 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 1996 | 110 | 0.030 |
Why?
|
Radionuclide Angiography | 1 | 2015 | 23 | 0.030 |
Why?
|
Microsomes, Liver | 2 | 1975 | 175 | 0.030 |
Why?
|
Centrosome | 1 | 2016 | 201 | 0.030 |
Why?
|
Mitral Valve Prolapse | 1 | 1997 | 231 | 0.030 |
Why?
|
Inhalation | 1 | 2015 | 143 | 0.030 |
Why?
|
Mitral Valve Stenosis | 1 | 1997 | 376 | 0.030 |
Why?
|
Time Factors | 7 | 2016 | 40063 | 0.030 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1975 | 143 | 0.030 |
Why?
|
Brain | 2 | 2018 | 26413 | 0.030 |
Why?
|
Heart Aneurysm | 1 | 1994 | 120 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2220 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2000 | 20817 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6274 | 0.030 |
Why?
|
Organs at Risk | 1 | 2015 | 346 | 0.030 |
Why?
|
Blood Volume | 1 | 1994 | 565 | 0.030 |
Why?
|
Myocardial Contraction | 2 | 2014 | 1585 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1995 | 478 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 1998 | 1312 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16687 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2016 | 1731 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2805 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3085 | 0.020 |
Why?
|
Hemoglobins | 2 | 1975 | 1533 | 0.020 |
Why?
|
Coronary Disease | 2 | 1996 | 6078 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1996 | 1573 | 0.020 |
Why?
|
Blood Circulation | 1 | 1991 | 251 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2016 | 1364 | 0.020 |
Why?
|
NADP | 3 | 1975 | 226 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1462 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2439 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 6 | 1975 | 2557 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15294 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1991 | 235 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4929 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 1997 | 1442 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1184 | 0.020 |
Why?
|
Animals | 14 | 2016 | 168788 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1914 | 0.020 |
Why?
|
Mediastinum | 1 | 2010 | 267 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 40559 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 1997 | 1072 | 0.020 |
Why?
|
Mice | 4 | 2016 | 81178 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2015 | 806 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18367 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2878 | 0.020 |
Why?
|
Linear Models | 2 | 2015 | 5953 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1183 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1421 | 0.020 |
Why?
|
Folic Acid Deficiency | 1 | 1979 | 115 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2009 | 459 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1998 | 2586 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2016 | 63119 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2009 | 297 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1504 | 0.020 |
Why?
|
NAD | 2 | 1975 | 594 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 1766 | 0.020 |
Why?
|
Streptomyces griseus | 1 | 1975 | 6 | 0.020 |
Why?
|
Supine Position | 1 | 1987 | 204 | 0.020 |
Why?
|
Hemerythrin | 1 | 1975 | 5 | 0.020 |
Why?
|
Thyroiditis | 1 | 2006 | 85 | 0.020 |
Why?
|
Hexosaminidases | 1 | 1975 | 54 | 0.020 |
Why?
|
Isocarboxazid | 1 | 1975 | 7 | 0.020 |
Why?
|
Digitoxin | 1 | 1975 | 22 | 0.020 |
Why?
|
Glutamate Dehydrogenase | 1 | 1975 | 52 | 0.020 |
Why?
|
Acetylglucosaminidase | 1 | 1975 | 70 | 0.020 |
Why?
|
Lung Volume Measurements | 1 | 1987 | 378 | 0.020 |
Why?
|
Esterases | 1 | 1975 | 95 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3340 | 0.020 |
Why?
|
Procaine | 1 | 1975 | 60 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 2958 | 0.020 |
Why?
|
Pepsin A | 1 | 1975 | 71 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 774 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 35423 | 0.020 |
Why?
|
Metalloproteins | 1 | 1975 | 100 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.020 |
Why?
|
Coronary Vessels | 1 | 1997 | 3107 | 0.020 |
Why?
|
Ifosfamide | 1 | 1975 | 228 | 0.020 |
Why?
|
Carcinosarcoma | 1 | 1975 | 108 | 0.020 |
Why?
|
Systole | 2 | 1998 | 957 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2015 | 57768 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 1997 | 11728 | 0.020 |
Why?
|
Amidohydrolases | 1 | 1975 | 169 | 0.020 |
Why?
|
Databases, Factual | 2 | 2015 | 7730 | 0.020 |
Why?
|
Sesquiterpenes | 1 | 1975 | 177 | 0.020 |
Why?
|
Uridine | 1 | 1975 | 146 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2015 | 13990 | 0.020 |
Why?
|
Oxygen | 1 | 1975 | 4187 | 0.010 |
Why?
|
Benzamides | 1 | 2009 | 1378 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2925 | 0.010 |
Why?
|
Electrocardiography | 3 | 1998 | 6442 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3270 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2619 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8661 | 0.010 |
Why?
|
Urea | 1 | 1975 | 451 | 0.010 |
Why?
|
Thyrotropin | 1 | 2006 | 850 | 0.010 |
Why?
|
Sheep | 2 | 1996 | 1437 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3611 | 0.010 |
Why?
|
Recurrence | 3 | 2002 | 8343 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12035 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1119 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1976 | 3058 | 0.010 |
Why?
|
RNA, Transfer | 1 | 1975 | 316 | 0.010 |
Why?
|
Spectrum Analysis | 2 | 1991 | 454 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 3 | 1975 | 220 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2017 | 0.010 |
Why?
|
Kinetics | 4 | 1975 | 6474 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 5987 | 0.010 |
Why?
|
Dogs | 2 | 1996 | 3913 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 1975 | 714 | 0.010 |
Why?
|
Muscle Proteins | 1 | 1975 | 1159 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 20945 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1975 | 2236 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2108 | 0.010 |
Why?
|
Catheterization | 2 | 1995 | 1469 | 0.010 |
Why?
|
Graft Rejection | 1 | 2012 | 4399 | 0.010 |
Why?
|
Immunity | 1 | 1975 | 1012 | 0.010 |
Why?
|
Ligands | 2 | 1975 | 3294 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 1998 | 193 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29784 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 8302 | 0.010 |
Why?
|
Tricuspid Valve Stenosis | 1 | 1997 | 32 | 0.010 |
Why?
|
Stroke | 1 | 2000 | 9981 | 0.010 |
Why?
|
Ultrasonography, Interventional | 2 | 1996 | 1483 | 0.010 |
Why?
|
Sex Distribution | 1 | 2002 | 2297 | 0.010 |
Why?
|
Schizophrenia | 1 | 1976 | 6882 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6757 | 0.010 |
Why?
|
Species Specificity | 3 | 1975 | 2480 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 1979 | 1912 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20123 | 0.010 |
Why?
|
Promazine | 1 | 1976 | 4 | 0.010 |
Why?
|
Age Distribution | 1 | 2002 | 2903 | 0.010 |
Why?
|
Trifluoperazine | 1 | 1976 | 40 | 0.010 |
Why?
|
Binding Sites | 2 | 1975 | 6116 | 0.010 |
Why?
|
Proteins | 2 | 2009 | 6101 | 0.010 |
Why?
|
Diastole | 1 | 1998 | 791 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1976 | 111 | 0.010 |
Why?
|
Swine | 2 | 1996 | 5940 | 0.010 |
Why?
|
Crohn Disease | 1 | 1979 | 2303 | 0.010 |
Why?
|
Mitochondria | 1 | 2009 | 3520 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2002 | 12355 | 0.010 |
Why?
|
Cobalt | 1 | 1975 | 158 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 1976 | 149 | 0.010 |
Why?
|
Folic Acid | 2 | 1979 | 1300 | 0.010 |
Why?
|
Cardiac Volume | 1 | 1996 | 210 | 0.010 |
Why?
|
Folic Acid Antagonists | 1 | 1975 | 84 | 0.010 |
Why?
|
Oxyhemoglobins | 1 | 1975 | 216 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1998 | 1903 | 0.010 |
Why?
|
Mathematics | 1 | 1975 | 728 | 0.010 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 1997 | 349 | 0.010 |
Why?
|
Protein Conformation | 2 | 1975 | 4012 | 0.010 |
Why?
|
Protein Binding | 2 | 1975 | 9392 | 0.010 |
Why?
|
Movement Disorders | 1 | 1976 | 445 | 0.010 |
Why?
|
United States | 1 | 2019 | 69867 | 0.010 |
Why?
|
Lactic Acid | 1 | 1996 | 1132 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 21824 | 0.010 |
Why?
|
Observer Variation | 1 | 1996 | 2593 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3509 | 0.010 |
Why?
|
Liver | 1 | 1975 | 7472 | 0.010 |
Why?
|
Propranolol | 1 | 1991 | 502 | 0.010 |
Why?
|
Structure-Activity Relationship | 2 | 1975 | 3133 | 0.010 |
Why?
|
Megaloblasts | 1 | 1979 | 1 | 0.010 |
Why?
|
Erythrocyte Aging | 1 | 1979 | 52 | 0.010 |
Why?
|
Temperature | 2 | 1975 | 2206 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12207 | 0.010 |
Why?
|
Sulfasalazine | 1 | 1979 | 79 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1997 | 6367 | 0.000 |
Why?
|
Artifacts | 1 | 1997 | 1903 | 0.000 |
Why?
|
Alcohol Drinking | 1 | 2000 | 3966 | 0.000 |
Why?
|
Massachusetts | 1 | 2000 | 8663 | 0.000 |
Why?
|
Iron | 1 | 1975 | 1774 | 0.000 |
Why?
|
Reference Values | 1 | 1994 | 4982 | 0.000 |
Why?
|
Cnidaria | 1 | 1975 | 14 | 0.000 |
Why?
|
Drug Combinations | 1 | 1991 | 1962 | 0.000 |
Why?
|
Digitoxigenin | 1 | 1975 | 11 | 0.000 |
Why?
|
Mortality | 1 | 1997 | 2864 | 0.000 |
Why?
|
Trichloroacetic Acid | 1 | 1975 | 33 | 0.000 |
Why?
|
Lethal Dose 50 | 1 | 1975 | 77 | 0.000 |
Why?
|
Chromatography, Thin Layer | 1 | 1975 | 223 | 0.000 |
Why?
|
Hydroxylation | 1 | 1975 | 141 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1975 | 326 | 0.000 |
Why?
|
Ketoglutaric Acids | 1 | 1975 | 78 | 0.000 |
Why?
|
Erythrocyte Count | 1 | 1975 | 163 | 0.000 |
Why?
|
Models, Molecular | 2 | 1975 | 5458 | 0.000 |
Why?
|
Fucose | 1 | 1975 | 125 | 0.000 |
Why?
|
Methods | 1 | 1975 | 1128 | 0.000 |
Why?
|
Logistic Models | 1 | 2000 | 13409 | 0.000 |
Why?
|
Plants, Medicinal | 1 | 1975 | 167 | 0.000 |
Why?
|
Triticum | 1 | 1975 | 86 | 0.000 |
Why?
|
Fourier Analysis | 1 | 1975 | 447 | 0.000 |
Why?
|
Subcellular Fractions | 1 | 1975 | 547 | 0.000 |
Why?
|
Molecular Conformation | 1 | 1975 | 563 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1975 | 376 | 0.000 |
Why?
|
Oligosaccharides | 1 | 1975 | 414 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1975 | 689 | 0.000 |
Why?
|
Plants | 1 | 1975 | 316 | 0.000 |
Why?
|
Computers | 1 | 1975 | 611 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2000 | 21752 | 0.000 |
Why?
|
Phospholipids | 1 | 1975 | 781 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1975 | 1584 | 0.000 |
Why?
|
Tyrosine | 1 | 1975 | 1461 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1979 | 2513 | 0.000 |
Why?
|
Metals | 1 | 1975 | 719 | 0.000 |
Why?
|
Chronic Disease | 1 | 1976 | 9147 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1975 | 2187 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1975 | 1275 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1975 | 1372 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1976 | 7908 | 0.000 |
Why?
|
Cattle | 1 | 1975 | 3922 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1997 | 8950 | 0.000 |
Why?
|
Erythrocytes | 1 | 1979 | 2454 | 0.000 |
Why?
|
Bone Marrow | 1 | 1979 | 2944 | 0.000 |
Why?
|
Hyperglycemia | 1 | 1975 | 1372 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 13885 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1975 | 3760 | 0.000 |
Why?
|
Saccharomyces cerevisiae | 1 | 1975 | 2752 | 0.000 |
Why?
|